Rebecca M. Minter, MD
A.R. Curreri Distinguished Chair, Department of Surgery
- Division of Surgical Oncology
Rebecca M. Minter, MD, is the A.R. Curreri Distinguished Chair of the Department of Surgery at the University of Wisconsin School of Medicine and Public Health. Prior to her move to the University of Wisconsin, Dr. Minter held successive leadership roles at the University of Texas Southwestern and the University of Michigan, including serving as Chief of the Hepatopancreatobiliary Section/Division at both institutions.
H4/710D Clinical Science Center
600 Highland Avenue
Madison WI 53792-7375
- MD, UT Southwestern Medical School, 1996
- Fellowship, University of Florida College of Medicine, Molecular Biology, 2000
- Residency, University of Florida College of Medicine, Surgery, 2003
Dr. Minter is certified by the American Board of Surgery. Her clinical practice is focused in the areas of pancreatobiliary and gastrointestinal surgery. She has a particular interest in the management and treatment of benign and neoplastic diseases of the pancreas. Dr. Minter is recognized as a clinical leader in her field and presently serves as the President of the Americas Hepatopancreatobiliary Association, current Chair of the International Hepatopancreatobiliary Association Education and Training Committee, and is an Associate Editor of the journal HPB.
Dr. Minter’s research efforts are primarily focused within the domain of surgical education. This work is focused on the development of training frameworks which explicitly define progressive entrustment and the development of autonomy. Dr. Minter holds national leadership positions in multiple societies in recognition of her work in the field of surgical education and academic surgery, and is the immediate past President of the Society of University Surgeons and the Fellowship Council.
- Entrustable Professional Activities: The Future of Competency-Based Education in Surgery May Already Be Here.
- Greenberg JA, Minter RM
- Ann. Surg. 2018 Dec 03;
- [PubMed ID: 30570541]
- Comparison of Overall Survival Between Preoperative Chemotherapy and Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma.
- Mokdad AA, Minter RM, Yopp AC, Porembka MR, Wang SC, Zhu H, Augustine MM, Mansour JC, Choti MA, Polanco PM
- J Natl Compr Canc Netw 2018 Dec; 16(12): 1468-1475
- [PubMed ID: 30545994]
- Non-home Discharge and Prolonged Length of Stay After Cytoreductive Surgery and HIPEC.
- Burguete D, Mokdad AA, Augustine MM, Minter R, Mansour JC, Choti MA, Polanco PM
- J. Surg. Res. 2019 Jan; 233: 360-367
- [PubMed ID: 30502272]
- Bridging the gap: The intersection of entrustability and perceived autonomy for surgical residents in the OR.
- Sandhu G, Thompson-Burdine J, Matusko N, Sutzko DC, Nikolian VC, Boniakowski A, Georgoff PE, Prabhu KA, Minter RM
- Am. J. Surg. 2019 Feb; 217(2): 276-280
- [PubMed ID: 30177241]
- Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis.
- Hester C, Nassour I, Adams-Huet B, Augustine M, Choti MA, Minter RM, Mansour JC, Polanco PM, Porembka MR, Wang SC, Yopp AC
- J. Gastrointest. Surg. 2018 Dec; 22(12): 2080-2087
- [PubMed ID: 30030718]